Cargando…

Dysregulation of FBW7 in malignant lymphoproliferative disorders

The ubiquitin-proteasome system (UPS) is involved in various aspects of cell processes, including cell proliferation, differentiation, and cell cycle progression. F-box and WD repeat domain-containing protein 7 (FBW7), as a key component of UPS proteins and a critical tumor suppressor in human cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Xin, Guo, Wei, Zhan, Zhumei, Bai, Ou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707496/
https://www.ncbi.nlm.nih.gov/pubmed/36457505
http://dx.doi.org/10.3389/fonc.2022.988138
_version_ 1784840715204820992
author Wan, Xin
Guo, Wei
Zhan, Zhumei
Bai, Ou
author_facet Wan, Xin
Guo, Wei
Zhan, Zhumei
Bai, Ou
author_sort Wan, Xin
collection PubMed
description The ubiquitin-proteasome system (UPS) is involved in various aspects of cell processes, including cell proliferation, differentiation, and cell cycle progression. F-box and WD repeat domain-containing protein 7 (FBW7), as a key component of UPS proteins and a critical tumor suppressor in human cancers, controls proteasome-mediated degradation by ubiquitinating oncoproteins such as c-Myc, Mcl-1, cyclin E, and Notch. It also plays a role in the development of various cancers, including solid and hematological malignancies, such as T-cell acute lymphoblastic leukemia, diffuse large B-cell lymphoma, and multiple myeloma. This comprehensive review emphasizes the functions, substrates, and expression of FBW7 in malignant lymphoproliferative disorders.
format Online
Article
Text
id pubmed-9707496
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97074962022-11-30 Dysregulation of FBW7 in malignant lymphoproliferative disorders Wan, Xin Guo, Wei Zhan, Zhumei Bai, Ou Front Oncol Oncology The ubiquitin-proteasome system (UPS) is involved in various aspects of cell processes, including cell proliferation, differentiation, and cell cycle progression. F-box and WD repeat domain-containing protein 7 (FBW7), as a key component of UPS proteins and a critical tumor suppressor in human cancers, controls proteasome-mediated degradation by ubiquitinating oncoproteins such as c-Myc, Mcl-1, cyclin E, and Notch. It also plays a role in the development of various cancers, including solid and hematological malignancies, such as T-cell acute lymphoblastic leukemia, diffuse large B-cell lymphoma, and multiple myeloma. This comprehensive review emphasizes the functions, substrates, and expression of FBW7 in malignant lymphoproliferative disorders. Frontiers Media S.A. 2022-11-09 /pmc/articles/PMC9707496/ /pubmed/36457505 http://dx.doi.org/10.3389/fonc.2022.988138 Text en Copyright © 2022 Wan, Guo, Zhan and Bai https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Wan, Xin
Guo, Wei
Zhan, Zhumei
Bai, Ou
Dysregulation of FBW7 in malignant lymphoproliferative disorders
title Dysregulation of FBW7 in malignant lymphoproliferative disorders
title_full Dysregulation of FBW7 in malignant lymphoproliferative disorders
title_fullStr Dysregulation of FBW7 in malignant lymphoproliferative disorders
title_full_unstemmed Dysregulation of FBW7 in malignant lymphoproliferative disorders
title_short Dysregulation of FBW7 in malignant lymphoproliferative disorders
title_sort dysregulation of fbw7 in malignant lymphoproliferative disorders
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707496/
https://www.ncbi.nlm.nih.gov/pubmed/36457505
http://dx.doi.org/10.3389/fonc.2022.988138
work_keys_str_mv AT wanxin dysregulationoffbw7inmalignantlymphoproliferativedisorders
AT guowei dysregulationoffbw7inmalignantlymphoproliferativedisorders
AT zhanzhumei dysregulationoffbw7inmalignantlymphoproliferativedisorders
AT baiou dysregulationoffbw7inmalignantlymphoproliferativedisorders